FDA.reportPublic FDA data

Application 220201

Type
NDA
Sponsor
AVYXA HOLDINGS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FAVLYXAFLUOROURACILSOLUTION;INTRAVENOUS250MG/10ML (25MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85156ORIG 2026-02-25
85113ORIG 2026-02-24